NDC 67877-172

Olanzapine

Olanzapine

Olanzapine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Ascend Laboratories, Llc. The primary component is Olanzapine.

Product ID67877-172_d39f7e44-89d1-4b24-adb1-fba49b25f578
NDC67877-172
Product TypeHuman Prescription Drug
Proprietary NameOlanzapine
Generic NameOlanzapine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2012-01-01
Marketing CategoryANDA / ANDA
Application NumberANDA202295
Labeler NameAscend Laboratories, LLC
Substance NameOLANZAPINE
Active Ingredient Strength3 mg/1
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 67877-172-01

100 TABLET in 1 BOTTLE (67877-172-01)
Marketing Start Date2012-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67877-172-85 [67877017285]

Olanzapine TABLET
Marketing CategoryANDA
Application NumberANDA202295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-01-01
Inactivation Date2020-01-31

NDC 67877-172-30 [67877017230]

Olanzapine TABLET
Marketing CategoryANDA
Application NumberANDA202295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-01-01
Inactivation Date2020-01-31

NDC 67877-172-10 [67877017210]

Olanzapine TABLET
Marketing CategoryANDA
Application NumberANDA202295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-01-01
Inactivation Date2020-01-31

NDC 67877-172-32 [67877017232]

Olanzapine TABLET
Marketing CategoryANDA
Application NumberANDA202295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-01-01
Inactivation Date2020-01-31

NDC 67877-172-01 [67877017201]

Olanzapine TABLET
Marketing CategoryANDA
Application NumberANDA202295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-01-01
Inactivation Date2020-01-31

NDC 67877-172-35 [67877017235]

Olanzapine TABLET
Marketing CategoryANDA
Application NumberANDA202295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-01-01
Inactivation Date2020-01-31

NDC 67877-172-33 [67877017233]

Olanzapine TABLET
Marketing CategoryANDA
Application NumberANDA202295
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-01-01

Drug Details

Active Ingredients

IngredientStrength
OLANZAPINE2.5 mg/1

OpenFDA Data

SPL SET ID:e8626e68-088d-47ff-bf06-489a778815aa
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200034
  • 312077
  • 312079
  • 312078
  • 314154
  • 283639

    • Pharmacological Class

    • Atypical Antipsychotic [EPC]

    NDC Crossover Matching brand name "Olanzapine" or generic name "Olanzapine"

    NDCBrand NameGeneric Name
    67877-175OlanzapineOlanzapine
    67877-174OlanzapineOlanzapine
    67877-172OlanzapineOlanzapine
    67877-173OlanzapineOlanzapine
    67877-176OlanzapineOlanzapine
    67877-177OlanzapineOlanzapine
    68084-529OlanzapineOlanzapine
    68084-723OlanzapineOlanzapine
    68084-528OlanzapineOlanzapine
    68084-740OlanzapineOlanzapine
    68084-525OlanzapineOlanzapine
    68258-7095OlanzapineOlanzapine
    68258-7152OlanzapineOlanzapine
    68258-7153OlanzapineOlanzapine
    68258-7154OlanzapineOlanzapine
    68382-365olanzapineolanzapine
    68382-368olanzapineolanzapine
    68258-7096OlanzapineOlanzapine
    68382-367olanzapineolanzapine
    68382-364olanzapineolanzapine
    68382-366olanzapineolanzapine
    68382-369olanzapineolanzapine
    68788-7161OlanzapineOlanzapine
    0517-0955OlanzapineOlanzapine
    69189-5510OlanzapineOlanzapine
    69543-384OlanzapineOlanzapine
    69543-380OlanzapineOlanzapine
    69543-381OlanzapineOlanzapine
    69543-383OlanzapineOlanzapine
    69543-382OlanzapineOlanzapine
    69543-385OlanzapineOlanzapine
    69807-2012OlanzapineOlanzapine
    69807-2011OlanzapineOlanzapine
    69807-2013OlanzapineOlanzapine
    70518-0026OlanzapineOlanzapine
    70518-0148OlanzapineOlanzapine
    70518-0145OlanzapineOlanzapine
    70518-0149OlanzapineOlanzapine
    70518-0314OlanzapineOlanzapine
    70518-0477OlanzapineOlanzapine
    70518-0110OlanzapineOlanzapine
    70518-0616OlanzapineOlanzapine
    70518-0144OlanzapineOlanzapine
    70518-0433OlanzapineOlanzapine
    70518-1206OlanzapineOlanzapine
    70518-0921OlanzapineOlanzapine
    70518-1207OlanzapineOlanzapine
    70518-0615OlanzapineOlanzapine
    70518-1115OlanzapineOlanzapine
    70518-1154OlanzapineOlanzapine
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.